PTC Therapeutics
PTCT
#2687
Rank
NZ$10.73 B
Marketcap
NZ$133.73
Share price
-0.76%
Change (1 day)
62.53%
Change (1 year)

PTC Therapeutics (PTCT) - Cash on Hand

Cash on Hand as of September 2025 : NZ$2.92 Billion

According to PTC Therapeutics 's latest financial reports the company has NZ$2.92 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

PTC Therapeutics - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$2.02 B45.77%
2023-12-31NZ$1.38 B114.32%
2022-12-31NZ$0.64 B-42.87%
2021-12-31NZ$1.13 B-25.98%
2020-12-31NZ$1.52 B50.04%
2019-12-31NZ$1.01 B200.46%
2018-12-31NZ$0.33 B26%
2017-12-31NZ$0.26 B-19.48%
2016-12-31NZ$0.33 B-32.46%
2015-12-31NZ$0.49 B23.08%
2014-12-31NZ$0.40 B132.07%
2013-12-31NZ$0.17 B5132.39%
2012-12-31NZ$3.31 M-90.9%
2011-12-31NZ$36.42 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Vertex Pharmaceuticals
VRTX
NZ$10.88 B 272.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$1.47 B-49.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.37 B-87.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
NZ$3.24 B 11.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.81 B-72.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$16.88 B 477.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland